Sign inJoin waitlistJoin the waitlist

JN

John Nemunaitis

Medical Oncology

Credentials: · · ·

History

Medical Oncology
1985–1987
Internal Medicine
1982–1985
Case Western Reserve University School of Medicine
1978–1982

Research

Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic…
Journal of Clinical Oncology · 2004 · 1,584 citations
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation
Journal of Clinical Oncology · 1997 · Last of 16 authors · 1,031 citations
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Journal of Clinical Oncology · 2006 · 897 citations

NS
Neil Senzer
77 papers
JS
Jack Singer
30 papers
FB
Francis Brunicardi
25 papers
CC
Charles Cunningham
23 papers
Adam Walter
21 papers
Frederick Appelbaum
19 papers
MB
Minal Barve
16 papers
Lance Dworkin
13 papers
Rodney Rocconi
13 papers
Danae Hamouda
11 papers · 6 as a fellow
KC
Khalil Choucair
11 papers · 10 as a resident
Susan Morand
11 papers · 2 as a resident

Clinical trials

Phase 1b Maintenance Therapy Study of ONT-10 in Patients With Solid Tumors
Principal investigator · Completed · Phase 1
Cascadian Therapeutics Inc.
2012–2016
Immune Response and Safety of HS110 Vaccine in Combination With Erlotinib in Patients With Non-Small Cell Lung Cancer
Principal investigator · Withdrawn · Phase 2
Heat Biologics
2011–2013
Blood for Immune Response to Provenge® in HRPC
Principal investigator · Withdrawn
Mary Crowley Medical Research Center
2011
Dose Escalation, Combination Chemotherapy Safety Study of Birinapant (TL32711), in Subjects With Advanced or Metastatic Solid Tumors
Principal investigator · Completed · Phase 1, Phase 2
TetraLogic Pharmaceuticals
2010–2014